FDA Approved: AMLODIPINE AND VALSARTAN — Supplemental Application (Lupin Pharmaceuticals,Inc.)

View source ↗

Summary

FDA approved a supplemental application for the fixed-dose combination of amlodipine and valsartan from Lupin Pharmaceuticals under ANDA202829.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• AMLODIPINE AND VALSARTAN (amlodipine and valsartan)

Snippet

SUPPL AP for AMLODIPINE AND VALSARTAN (AMLODIPINE AND VALSARTAN)